IGF-1 DES
Also: DES(1-3)IGF-1
Ultra-potent short-acting IGF-1 variant for localized hypertrophy.
Evidence
anecdotal
Legal status
research only
Half-life
Short (~hours)
Routes
subq
What it is
Ultra-potent short-acting IGF-1 variant for localized hypertrophy.
Mechanism
Ultra-potent short-acting IGF-1 variant for localized hypertrophy.
Outcomes it's matched to
- STRENGTH70%
- STRENGTH70%
Safety
Educational reference only. Long-term human safety varies; consult a peptide-literate clinician.
Legal context
Research chemical